{"id":"W3212572680","doi":"10.1182/blood-2021-146003","title":"Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Tolerability; Internal medicine; Multiple myeloma; Adverse effect; Population; Discontinuation; Oncology; Neutropenia; Gastroenterology; Pharmacology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001596244,0.00009308296,0.0001843851,0.00003098735,0.00001568457,0.000008170401,0.00004378802,0.00008525832,0.000002072248],"category_scores_gemma":[0.0001065495,0.00006089143,0.00001809158,0.0001461894,0.00003780369,0.000006453794,0.00003017121,0.0001032767,1.794883e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007489291,"about_ca_system_score_gemma":0.00003039199,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005079482,"about_ca_topic_score_gemma":0.005472858,"domain_scores_codex":[0.9991226,0.0001810215,0.0002531437,0.0002667537,0.00008864977,0.00008789597],"domain_scores_gemma":[0.9995918,0.00003458522,0.00009100275,0.0001979257,0.00006570074,0.0000190134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006833641,0.001923879,0.988198,0.000004142929,0.00006153299,0.000005140078,0.0002885555,0.000008790078,0.004573383,6.441253e-7,0.000004445047,0.004248078],"study_design_scores_gemma":[0.01346058,0.001665563,0.9790683,0.00002466114,0.00005294674,0.000002491472,0.0005438528,0.00001661352,0.005064896,0.000006285225,0.00001825028,0.00007555391],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993808,0.0001000541,0.000005343769,0.0000370818,0.000033442,0.000421882,0.000006876975,0.000003234852,0.00001130782],"genre_scores_gemma":[0.9994239,0.00004148157,0.000340729,0.00002276434,0.00002004953,0.00001466655,0.0001110476,0.00001097229,0.00001434594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01277722,"threshold_uncertainty_score":0.3053983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008855952597589074,"score_gpt":0.2450804213932807,"score_spread":0.2362244687956916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}